You are here

Eloctate

Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal

Endpoints

Mon, 07/29/19 - 09:39 am

Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch

Fierce Pharma

Fri, 04/26/19 - 07:39 pm

Disruption of the Year: Long-Acting Hemophilia Drugs

BioPharma Dive

Tue, 12/5/17 - 09:34 am

Biogen explores sale of hemophilia assets -sources

Yahoo/Reuters

Fri, 04/8/16 - 09:59 pm

3 Reasons That Biogen's Shares Could Rise

Investopedia

Wed, 06/17/15 - 10:05 am

Alzheimer's disease

Are These Biogen Idec's Next Blockbusters?

Investopedia

Tue, 03/10/15 - 08:10 am

Biogen Hemophilia Drugs Launch Into The Unknown

Investors.com

Mon, 06/30/14 - 05:53 pm

U.S. FDA approves Biogen's hemophilia A drug Eloctate

Yahoo/Reuters

Sat, 06/7/14 - 08:59 am

FDA approves Biogen's hemophilia A drug Eloctate

Yahoo/Reuters

Fri, 06/6/14 - 05:22 pm

Biogen shares could rise 20% on robust drug pipeline, Barron's contends

The Fly on the Wall

Fri, 05/23/14 - 06:58 am

Biogen's blood disorder drug succeeds in late-stage trial

Yahoo/Reuters

Thu, 04/10/14 - 07:49 am

Biogen Idec: More Pipeline Success, More Upside

Barron's

Thu, 03/6/14 - 10:30 am

Here's Why Biogen Could Be in Store for a Big 2014

Motley Fool

Wed, 02/12/14 - 06:48 pm

Biogen’s Hemophilia Drug Delay May Push Sales to Mid-2014

Bloomberg

Tue, 11/12/13 - 01:09 pm